Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 113.30
+0.30 (0.27%)
Jan 2, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 104.09 billion as of January 2, 2026. Its market cap has increased by 77.87% in one year.
Market Cap
104.09B
Enterprise Value
101.15B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
113.30
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 104.09B, an increase of 461.31%. That is a compound annual growth rate of 35.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.67B |
| Hansoh Pharmaceutical Group Company | 218.43B |
| JD Health International | 178.11B |
| Innovent Biologics | 131.21B |
| WuXi Biologics | 129.79B |
| Sino Biopharmaceutical | 110.48B |
| CSPC Pharmaceutical Group | 96.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 91.46B |